Literature DB >> 21633851

Glucosidase acid beta gene mutations in Egyptian children with Gaucher disease and relation to disease phenotypes.

Zakarya El-Morsy1, Mohamed T Khashaba, Othman El-Sayed Soliman, Sohier Yahia, Dina Abd El-Hady.   

Abstract

INTRODUCTION: More than 200 mutations have been found in patients with Gaucher disease (GD) and some mutations usually have a high frequency in certain populations. Genotype/phenotype correlation in patients with GD has not been established. This study was designed to determine underlying mutations in Egyptian children with GD and to assess their relation to disease phenotypes.
METHODS: This study comprised 17 patients with GD and 10 healthy controls. Thirteen patients were type 1 GD, 2 type 2, and 2 type 3. DNA was extracted from peripheral blood leukocytes. Exons 9 and 10 were amplified by polymerase chain reaction, and deoxyribonucleic acid sequencing was done with an ABI 310 genetic analyzer.
RESULTS: Wild type allele was detected in 95% (19/20) and a normal variant in 5% (1/20) of controls. L444P allele was encountered in 50% (13/26) of the alleles in type 1 patients, H451P in 7.7% (2/26) and recombinant alleles (RecNcil, RecNcil + M450L, RecFs, RecFs + M450L) in 34.6% (9/26). L444P and Rec alleles each occurred in 50% (2/4) of type 2 and 3 patients. A new mutation was seen in this study {g.7336A>C, (M450L)} and 2 mutant alleles were not determined. Type 1 GD patients had L444P/L444P genotype (23.1%) and Rec alleles/L444P (53.8%), while type 2 and 3 GD patients had Rec alleles/L444P genotypes (100%) with a poor phenotype/genotype correlation.
CONCLUSIONS: L444P and Rec alleles are common in the studied patients. Novel mutations are continuously detected, adding to the expanding panel of GD mutations. No significant genotype-phenotype association was observed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633851     DOI: 10.1007/s12519-011-0309-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  30 in total

1.  Hematologically important mutations: Gaucher disease.

Authors:  E Beutler; T Gelbart
Journal:  Blood Cells Mol Dis       Date:  1998-03       Impact factor: 3.039

2.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

3.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.

Authors:  Nahid Tayebi; Barbara K Stubblefield; Joseph K Park; Eduard Orvisky; Jamie M Walker; Mary E LaMarca; Ellen Sidransky
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

4.  Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.

Authors:  A El-Beshlawy; L Ragab; I Youssry; K Yakout; H El-Kiki; K Eid; I M Mansour; S Abd El-Hamid; M Yang; P K Mistry
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

5.  Heterologous expression and characterization of a rare Gaucher disease mutation (c.481C > T) from a Canadian aboriginal population using archival tissue samples.

Authors:  G Sinclair; F Y Choy; P Ferreira
Journal:  Mol Genet Metab       Date:  2001-11       Impact factor: 4.797

6.  Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.

Authors:  Serap Emre; Figen Gürakan; Aysel Yüce; Arnold Rolf; Ronald Scott; Hasan Ozen
Journal:  Eur J Med Genet       Date:  2008-03-04       Impact factor: 2.708

Review 7.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

Review 8.  Gaucher disease: complexity in a "simple" disorder.

Authors:  Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

9.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Gaucher's disease: identification of novel mutant alleles and genotype-phenotype relationships.

Authors:  H Zhao; M Keddache; L Bailey; Gl Arnold; G Grabowski
Journal:  Clin Genet       Date:  2003-07       Impact factor: 4.438

View more
  4 in total

1.  Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.

Authors:  Azza Abdel Gawad Tantawy; Eman Mounir Sherif; Amira Abdel Moneam Adly; Sahar Hassanine; Amina Hafez Awad
Journal:  J Inherit Metab Dis       Date:  2013-03-19       Impact factor: 4.982

2.  Twenty- five years of biochemical diagnosis of Gaucher disease: the Egyptian experience.

Authors:  Ekram Fateen; Zeinab Y Abdallah
Journal:  Heliyon       Date:  2019-11-01

3.  Long-term follow-up and sudden unexpected death in Gaucher disease type 3 in Egypt.

Authors:  Magy Abdelwahab; Derek Blankenship; Raphael Schiffmann
Journal:  Neurol Genet       Date:  2016-02-25

4.  Gaucher disease in Syrian children: common mutations identification, and clinical futures.

Authors:  Diana Alasmar
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.